The pathological damage and deterioration of renal function in DKD can be improved by exogenous SCFAs, particularly butyric acid, through the inhibition of oxidative stress and NF-kB signaling mediated by GPR43 (Huang et al. 2020). The gene discussed is FFAR2; the disease is diabetic kidney disease.